blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0745086

EP0745086 - TRICYCLIC SPIROPIPERIDINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.02.1998
Database last updated on 19.07.2024
Most recent event   Tooltip13.02.1998Application deemed to be withdrawnpublished on 01.04.1998 [1998/14]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1996/49]For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / CLAREMON, David, A.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / PONTICELLO, Gerald, S.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / SELNICK, Harold, G.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[1996/49]
Representative(s)Hiscock, Ian James
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1996/49]Hiscock, Ian James
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date95911762.315.02.1995
[1996/49]
WO1995US01960
Priority number, dateUS1994019894018.02.1994         Original published format: US 198940
[1996/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9522548
Date:24.08.1995
Language:EN
[1995/36]
Type: A1 Application with search report 
No.:EP0745086
Date:04.12.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 24.08.1995 takes the place of the publication of the European patent application.
[1996/49]
Search report(s)International search report - published on:US24.08.1995
(Supplementary) European search report - dispatched on:EP27.06.1997
ClassificationIPC:C07D491/107, C07D221/20, A61K31/435, // (C07D491/107, 311:00, 221:00)
[1997/18]
CPC:
C07D221/20 (EP,US); A61P9/06 (EP); C07D491/10 (EP,US)
Former IPC [1996/49]C07D491/107, C07D221/20, A61K31/55, A61K31/70, A61K31/735, A61K31/445
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1996/49]
TitleGerman:TRICYCLISCHE SPIROPIPERIDINE[1996/49]
English:TRICYCLIC SPIROPIPERIDINES[1996/49]
French:SPIROPIPERIDINES TRICYCLIQUES[1996/49]
Entry into regional phase18.09.1996National basic fee paid 
18.09.1996Search fee paid 
18.09.1996Designation fee(s) paid 
18.09.1996Examination fee paid 
Examination procedure24.08.1995Request for preliminary examination filed
International Preliminary Examining Authority: US
18.09.1996Examination requested  [1996/49]
23.09.1997Application deemed to be withdrawn, date of legal effect  [1998/14]
23.10.1997Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1998/14]
Fees paidRenewal fee
28.02.1997Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0431943  (MERCK & CO INC [US]) [X] 1-3,5-12 * examples 237,451; claims 1-5,9,10 * * page 146; table XXXVIII, 4th compound *;
 US5206240  [ ] (BALDWIN JOHN J [US], et al);
 [PX]WO9417045  (MERCK & CO INC [US], et al) [PX] 1,3-5,7,8 * claims 1-3,6,7 *;
 [PX]WO9418204  (MERCK & CO INC [US], et al) [PX] 1,2,4-12 * examples 46,47,49,50; claims 1,10-13 *;
 [PA]WO9501335  (MERCK & CO INC [US], et al) [PA] 1-14 * claims 1-3,9-19 *;
 US5382587  [ ] (BALDWIN JOHN J [US], et al)
 [A]  - ELLIOT J.M. ET AL., "4-Oxospiro[benzopyran-2,4'-piperidines] as class III antiarrhythmic agents. Pharmacological studies on 3,4-dihydro-1'-[2-(benzofurazan-5-yl)-ethyl]-6-methanesulfonamidospiro[(2H)-1-benzopyran-2,4'-piperidin]-4-one (L-691,121)", JOURNAL OF MEDICINAL CHEMISTRY, (19921016), vol. 35, no. 21, pages 3973 - 3976, XP000611486 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00099a028
International search[AP]US5382587  (BALDWIN JOHN J [US], et al);
 [A]US5206240  (BALDWIN JOHN J [US], et al);
 [A]US5219860  (CHAMBERS MARK S [GB], et al);
 [A]US5091387  (EVANS BEN E [US], et al);
 [XP]WO9418204  (MERCK & CO INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.